These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6968159)

  • 1. Prospective study of immune response to hydralazine and development of antideoxyribonucleoprotein in patients receiving hydralazine.
    Carpenter JR; McDuffie FC; Sheps SG; Spiekerman RE; Brumfield H; King R
    Am J Med; 1980 Sep; 69(3):395-400. PubMed ID: 6968159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between immune response to hydralazine and to deoxyribonuclease in patients receiving hydralazine.
    McDuffie FC
    Arthritis Rheum; 1981 Aug; 24(8):1079-81. PubMed ID: 6974555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to hydralazine and nuclear antigens in hydralazine-induced lupus erythematosus.
    Hahn BH; Sharp GC; Irvin WS; Kantor OS; Gardner CA; Bagby MK; Perry HM; Osterland CK
    Ann Intern Med; 1972 Mar; 76(3):365-74. PubMed ID: 4536922
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydralazine, antinuclear antibodies, and the lupus syndrome.
    Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytotoxic antibodies in hydralazine-induced lupus erythematosus.
    Ryan PF; Hughes GR; Bernstein R; Mansilla R; Dollery CT
    Lancet; 1979 Dec; 2(8154):1248-9. PubMed ID: 92663
    [No Abstract]   [Full Text] [Related]  

  • 7. Patterns of antinuclear antibodies and lupus-activating drugs.
    Alarcon-Segovia D; Fishbein E
    J Rheumatol; 1975 Jun; 2(2):167-71. PubMed ID: 1080200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of immunologic effects of hydralazine in hypertensive patients.
    Litwin A; Adams LE; Zimmer H; Foad B; Loggie JH; Hess EV
    Clin Pharmacol Ther; 1981 Apr; 29(4):447-56. PubMed ID: 6970646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the pathogenesis of hydralazine-induced lupus erythematosus-like syndrome (author's transl)].
    Yamauchi Y
    Ryumachi; 1979 Apr; 19(2):88-104. PubMed ID: 312536
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydrallazine in hypertension: is there a safe dose?
    Bing RF; Russell GI; Thurston H; Swales JD
    Br Med J; 1980 Aug; 281(6236):353-4. PubMed ID: 6968614
    [No Abstract]   [Full Text] [Related]  

  • 11. Antinuclear antibodies as indicators for the procainamide-induced systemic lupus erythematosus-like syndrome and its clinical presentations.
    Gorsulowsky DC; Bank PW; Goldberg AD; Lee TG; Heinzerling RH; Burnham TK
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):245-53. PubMed ID: 3882781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine antinuclear antibodies and the lupus syndrome.
    Ramsay LE; Silas J; Freestone S
    Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1711. PubMed ID: 6805676
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.
    Yamauchi Y; Litwin A; Adams L; Zimmer H; Hess EV
    J Clin Invest; 1975 Oct; 56(4):958-69. PubMed ID: 808562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus.
    Reza MJ; Dornfeld L; Goldberg LS
    Arthritis Rheum; 1975; 18(4):335-8. PubMed ID: 50845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydralazine-induced lupus erythematosus-like syndrome.
    Irias JJ
    Am J Dis Child; 1975 Jul; 129(7):862-4. PubMed ID: 50009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
    Cartee TV; Chen SC
    Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hydralazine-induced lupus presenting as systemic lupus erythematosus.
    Rubin RL; Haluptzok RF; Davila LM
    Lupus; 2020 Apr; 29(5):509-513. PubMed ID: 32041503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and theoretical interest of the immunochemical analysis of antinuclear antibodies in systemic lupus erythematosus.
    Tron F; Jacob L; Bach JF
    Adv Nephrol Necker Hosp; 1983; 12():215-37. PubMed ID: 6188347
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies.
    Alarcón-Segovia D
    Rev Invest Clin; 1972; 24(2):167-74. PubMed ID: 4538312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.